Cannaxan GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.cannaxan.de/en
Clinical Trials
7
Active:1
Completed:2
Trial Phases
1 Phases
Phase 1:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (100.0%)Clinical Trial on Pharmacokinetics and Tolerability of AP707
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- CannaXan GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT05267769
- Locations
- 🇩🇪
Phase I Unit of CannaXan GmbH, Warngau, Bavaria, Germany
Clinical Trial on Pharmacokinetic and Tolerability of AP701
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- CannaXan GmbH
- Target Recruit Count
- 15
- Registration Number
- NCT04708795
- Locations
- 🇩🇪
Phase I Unit of CannaXan GmbH, Warngau, Bavaria, Germany
News
No news found